Evidence map›Paper›PMID 38704509›Full record

ArticleCommunications biology2024

The implications of APOBEC3-mediated C-to-U RNA editing for human disease.

Melissa Van Norden, Zackary Falls, Sapan Mandloi, Brahm H Segal, Bora E Baysal, Ram Samudrala, Peter L Elkin

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Multi-Tissue Genetic Regulation of RNA Editing in Pigs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. MiREDiBase: A Comprehensive Resource for miRNA Editing Events.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Melissa Van NordenDepartment of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.ORCID 0000-0002-6190-7381
Zackary FallsDepartment of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.ORCID 0000-0003-4116-0441
Sapan MandloiDepartment of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Brahm H SegalDepartment of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.ORCID 0000-0001-5043-7380
Bora E BaysalRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Ram SamudralaDepartment of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.ORCID 0000-0001-9069-8497
Peter L ElkinDepartment of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA. elkinp@buffalo.edu.ORCID 0000-0001-9616-6811

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
National Library of Medicine Conference 2022T15LM012495 · NLM · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PETER L. ELKIN · 2017 to 2026
$4.3M
A translational bioinformatics approach to elucidate and mitigate polypharmacy induced adverse drug reactionsK01DA056690 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Zackary Michael Falls · 2022 to 2026
$1.0M
Acquisition of High Performance Data and Computing Infrastructure to Advance Biomedical ResearchS10OD024973 · OD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FURLANI, THOMAS · 2019 to 2019
$1.0M
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and EducationR25LM014213 · NLM · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PETER L. ELKIN, RAM SAMUDRALA · 2022 to 2026
$668k
Pain Medication Prescriptions and Misuse Following Treatment for Alcohol Use DisordersR21AA026954 · NIAAA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI ELKIN, PETER L., LEONARD, KENNETH E · 2018 to 2019
$386k
NCATS NIH HHS UL1 TR001412NIAAA NIH HHS R21 AA026954NIDA NIH HHS K01 DA056690NLM NIH HHS R25 LM014213NLM NIH HHS T15 LM012495U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (NLM) LMR1514213U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (NLM) LMT15012495U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (NLM) LMT1512495
6 · The paper itself

Abstract

Intra-organism biodiversity is thought to arise from epigenetic modification of constituent genes and post-translational modifications of translated proteins. Here, we show that post-transcriptional modifications, like RNA editing, may also contribute. RNA editing enzymes APOBEC3A and APOBEC3G catalyze the deamination of cytosine to uracil. RNAsee (RNA site editing evaluation) is a computational tool developed to predict the cytosines edited by these enzymes. We find that 4.5% of non-synonymous DNA single nucleotide polymorphisms that result in cytosine to uracil changes in RNA are probable sites for APOBEC3A/G RNA editing; the variant proteins created by such polymorphisms may also result from transient RNA editing. These polymorphisms are associated with over 20% of Medical Subject Headings across ten categories of disease, including nutritional and metabolic, neoplastic, cardiovascular, and nervous system diseases. Because RNA editing is transient and not organism-wide, future work is necessary to confirm the extent and effects of such editing in humans.

Indexed as

APOBEC DeaminasesCytidine DeaminaseRNA EditingAPOBEC-3G DeaminaseCytosineCytosine DeaminaseHumansPolymorphism, Single NucleotideProteinsUracilAPOBEC3A protein, humanAPOBEC-3G DeaminaseAPOBEC3G protein, humanAPOBEC3 proteins, humanAPOBEC DeaminasesCytidine DeaminaseCytosineCytosine DeaminaseProteinsUracil

Identifiers

PMID38704509
PMCPMC11069577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.